Navigation Links
Medicaid-insured children have limited access to dermatologists, SLU researchers find
Date:4/29/2013

ST. LOUIS A recent Saint Louis University study revealed that Medicaid-insured children with eczema, an inflammatory skin condition that affects 20 percent children in the United States, do not have easy access to dermatologists.

"This is a complex problem and a major health disparity in our country," said Elaine Siegfried, M.D., professor of pediatrics at SLU and the principal investigator of the study. "Thirty percent of all children seen in primary care offices have a skin problem. It's an everyday issue."

SLU researchers found that only 19 percent of all dermatologists in 13 metropolitan areas across the United States accept Medicaid-insured children. Of the 471 dermatologists who were listed as Medicaid-participating providers by Medicaid insurance plans, 44 percent declined to schedule a new Medicaid-insured child.

"The purpose of this study was to compare access to dermatologists for new pediatric patients with eczema insured by Medicaid verus private plans," said Sofia Chaudhry, M.D., assistant professor of dermatology at SLU and the first author of the study, which was published online in the Journal of American Academy of Dermatology last month.

In this secret-shopper survey, researchers posed as parents and called dermatology offices across the country to request an appointment for their child with eczema. Even when a dermatologist was accepting new Medicaid-insured children, these children were more often required to provide a written referral and/or identification numbers before an appointment date could be offered, in comparison to privately-insured children.

Eczema mainly affects children and is often a chronic condition in which the skin becomes itchy, reddened, cracked and dry. In addition to the physical effects, eczema also impacts the quality of life, causing emotional, behavioral and sleep disturbances.

"Since it can be a chronic debilitating disease, it's important for these children to be able to see a dermatologist," said Chaudhry, who is also a SLUCare dermatologist. "Improved access to dermatologists is important for treating eczema in order to enhance the well-being of affected children and to minimize the expensive cost of emergency care," Chaudhry added.

About 32 million children are insured with Medicaid health insurance plans, and that number is likely to expand by 16 to 18 million with the new health care reform.

Chaudhry and other researchers identified several possible factors that may discourage dermatologists from seeing a Medicaid-insured patient. These include a physician's concern of additional administrative paperwork, convoluted or delayed payments, a high no-show rate of patients, extra time required to address patients with complex social issues and possible medical-legal liabilities associated with them.


'/>"/>

Contact: Riya V. Anandwala
ranandwa@slu.edu
314-977-8018
Saint Louis University
Source:Eurekalert

Related medicine news :

1. Learning disabilities affect up to 10 percent of children and co-occur at higher than expected rates
2. New study shows children routinely injured or killed by guns
3. ProRehab Partners with Global Non-profit Organization to Help Comfort Children Suffering from Serious Illness
4. Facial dog bites in children may require repeated plastic surgery
5. Hasbro Childrens Hospital physician receives $3.2 million grant to study teen alcohol use
6. Cleveland Clinic Childrens Hospital research suggests transmission of respiratory viruses in utero
7. Beaumont Childrens Hospital pediatrician inducted into Legends of Neonatology Hall of Fame
8. Children and teens with autism more likely to become preoccupied with video games
9. Helping Children Make Sense of the Senseless
10. Nia Vardalos Speaks Out on Adoption, Bolsters Legal Support for Abused Children
11. Austin Oral Surgery Donates to the Children at Heart Golf Marathon to Benefit Children at Heart Ministries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/25/2017)... ... September 25, 2017 , ... Ron ... an option to senior, upper-level executives speaking at a business luncheon today, "It ... high-level executive is an asset to be fully realized and activated by the ...
(Date:9/25/2017)... ... September 25, 2017 , ... “Renew Refresh Restore Reward”: is a ... Reward” is the creation of published author, Deborah Freeman, cofounded the Free Spirit Bible ... we returned to our cars, my sister-in-law invited us to come over before the ...
(Date:9/25/2017)... September 25, 2017 - Orlando, FL, Microsoft Ignite Conference (PRWEB) , ... ... ... Hosts, Inc . announced today that they have teamed up to deliver Netmail’s Hadron ... on-demand service from a HIPAA/HITRUST compliant Azure Cloud. Netmail will be demo-ing their Hadron ...
(Date:9/25/2017)... ... ... Ash Borers kill Ash trees in as little as 1-3 years. The signs ... by Rob Nagy, ISA Certified Arborist at Giroud Tree and Lawn, shows a street in ... signs of decline from Emerald Ash Borers, two Ash trees continue to thrive. ...
(Date:9/24/2017)... & Caicos Islands, BWI (PRWEB) , ... September 25, 2017 , ... ... to announce the resort is re-opening on October 1st. And, throughout the month ... three bedroom oceanfront rentals. , Hurricane Irma and Maria have passed and damage ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)...   BioLife Solutions , Inc. (NASDAQ: BLFS ... grade cell and tissue hypothermic storage and ... , President and CEO, will be presenting at two investment ... Renshaw 19 th Annual Global Investment Conference on Tuesday, ... time). The conference is being held at the New York ...
(Date:9/6/2017)... Eli Lilly and Company (NYSE: LLY ) ... and lasmiditan, two investigational treatments for migraine, at the ... place Sept. 7-10 in Vancouver . ... from an open-label study evaluating the safety and effectiveness ... mg) for the prevention of migraine. Galcanezumab is a ...
(Date:9/5/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) (TASE: ... on the development of oral drug delivery systems, announced ... the U.S. Food and Drug Administration (FDA) regarding ORMD-0801, ... At the meeting, the FDA gave ... ORMD-0801, would be a Biologics License Application (BLA).  Such ...
Breaking Medicine Technology: